SLC2A2 and diabetes mellitus: In our animal experiments, we used STZ to induce diabetes because STZ selectively destroys pancreatic islet β cells via the GLUT2 glucose transporter, which resulted in animals experiencing general characteristics of human diabetes such as hyperglycemia, polyuria, polydipsia and hyperphagia.22